fda to stop compounded semaglutide Novo asks bar compounders from making copies FDA crackdown on off-brand Ozempic

In view of recent advances in genomic technologies, targeted panels currently used to this purpose will be replaced by exome or genome sequencing

Treat measurement as a core skill: track average bet size, volatility tolerance, and how different features align with your enjoyment curve

Hutchings, H., Ortega, N

The market reaction was positive because this was not just a headline beat

Several mechanisms have been proposed by which virally induced inflammation increases insulin resistance 39

I understand Kaiser removed GLP-1 weight loss medications (like Wegovy/Wegovy) from base coverage in 2025, but some employers opted to add this benefit